EPA:ALMDT - Euronext Paris - Matif - FR0011049824 - Common Stock - Currency: EUR
MEDIAN TECHNOLOGIES
EPA:ALMDT (2/4/2025, 7:00:00 PM)
3.35
-0.72 (-17.69%)
The current stock price of ALMDT.PA is 3.35 EUR. In the past month the price decreased by -18.19%. In the past year, price decreased by -13.21%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 37.14 | 36.66B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.58 | 1.23B | ||
NXU.DE | NEXUS AG | 44.26 | 1.18B | ||
EQS.PA | EQUASENS | 11.81 | 555.22M | ||
CONTX.OL | CONTEXTVISION AB | 18.14 | 393.04M | ||
GPI.MI | GPI SPA | 3 | 276.67M | ||
CGM.PA | CEGEDIM SA | 80 | 169.20M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 138.25M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
AJ91.DE | DOCCHECK AG | 18.65 | 45.38M | ||
ALINS.PA | INTRASENSE SAS | N/A | 14.21M |
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca and currently employs 250 full-time employees. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
MEDIAN TECHNOLOGIES
Les Deux Arcs - Batiment B 1800, Route des Cretes
Valbonne PACA FR
Employees: 256
Company Website: https://mediantechnologies.com/
Investor Relations: http://mediantechnologies.com/investors/
Phone: 33493333777
The current stock price of ALMDT.PA is 3.35 EUR.
The exchange symbol of MEDIAN TECHNOLOGIES is ALMDT and it is listed on the Euronext Paris - Matif exchange.
ALMDT.PA stock is listed on the Euronext Paris - Matif exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ALMDT.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ALMDT.PA.
ALMDT.PA does not pay a dividend.
ALMDT.PA does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.29).
ChartMill assigns a technical rating of 1 / 10 to ALMDT.PA. When comparing the yearly performance of all stocks, ALMDT.PA is a bad performer in the overall market: 91.44% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA. ALMDT.PA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALMDT.PA reported a non-GAAP Earnings per Share(EPS) of -1.29. The EPS decreased by 3.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -77.03% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 85% to ALMDT.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 13.62% and a revenue growth -5.29% for ALMDT.PA